Browsing by Subject Blood platelet disorders

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)
2024Allogeneic platelet-rich plasma for knee osteoarthritis in patients with primary immune thrombocytopenia : a randomized clinical trialZhu, Xiaohang; Zhao, Lingying; Riva, Nicoletta; Yu, Ziqiang; Jiang, Miao; Zhou, Feng; Gatt, Alexander; Giannoudis, Peter V.; Guo, Jiong Jiong
2015-10Comparison between a point-of-care and a laboratory-based CYP2C19*2 genotyping assay for pharmacist-led personalisation of antiplatelet therapyWirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M.
2007Completing the audit cycle : comparison of cardiac risk factor management in patients with intermittent claudication in two time periodsWilson, Alasdair M.; Bachoo, Paul; Mackay, Ian A.; Cassar, Kevin; Brittenden, Julie
2003Management of secondary risk factors in patients with intermittent claudicationCassar, Kevin; Coull, Robbie; Bachoo, Paul; Macaulay, E. M.; Brittenden, Julie
2016-03Pharmacist-led rapid point-of-care CYP2C19 genotyping for individualisation of antiplatelet therapyWirth, Francesca; Xuereb, Robert G.; Fenech, Albert; Azzopardi, Lilian M.
2017Primary immune thrombocytopenia in adults : clinical practice versus management guidelinesNg, Thomas; Gatt, Alexander; Smith, Mark
1971Purpura in the newbornJaccarini, Carol J.; Busuttil, Tancred
2005Randomized clinical trial of the antiplatelet effects of aspirin–clopidogrel combination versus aspirin alone after lower limb angioplastyCassar, Kevin; Ford, Isobel; Greaves, Mike; Bachoo, Paul; Brittenden, Julie
2017-01Rapid point-of-care CYP2C19*2 genotyping to personalise antiplatelet therapy in patients undergoing coronary stentingWirth, Francesca; Xuereb, Robert G.; Fenech, Albert; Azzopardi, Lilian M.